These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 3054233

  • 1. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH, Resnick LM.
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [Abstract] [Full Text] [Related]

  • 2. Two forms of vasoconstriction in systemic hypertension.
    Laragh JH.
    Am J Cardiol; 1987 Oct 30; 60(12):82G-93G. PubMed ID: 3314453
    [Abstract] [Full Text] [Related]

  • 3. Clinical parameters of concern in the pathology and treatment of hypertension.
    Laragh JH.
    J Clin Hypertens; 1986 Sep 30; 2(3 Suppl):1S-11S. PubMed ID: 2947978
    [Abstract] [Full Text] [Related]

  • 4. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ, Laragh JH, Atlas SA, Case DB.
    J Hypertens Suppl; 1983 Oct 30; 1(1):77-84. PubMed ID: 6085835
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology of diastolic hypertension.
    Laragh JH.
    Health Psychol; 1988 Oct 30; 7 Suppl():15-31. PubMed ID: 3072177
    [Abstract] [Full Text] [Related]

  • 6. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF, Laragh JH.
    Urol Clin North Am; 1975 Jun 30; 2(2):237-57. PubMed ID: 1098253
    [Abstract] [Full Text] [Related]

  • 7. Issues, goals, and guidelines in selecting first-line drug therapy for hypertension.
    Laragh JH.
    Hypertension; 1989 May 30; 13(5 Suppl):I103-12. PubMed ID: 2490815
    [Abstract] [Full Text] [Related]

  • 8. The renin system and new understanding of the complications of hypertension and their treatment.
    Laragh JH.
    Arzneimittelforschung; 1993 Feb 30; 43(2A):247-54. PubMed ID: 8498972
    [Abstract] [Full Text] [Related]

  • 9. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
    Laragh JH, Sealey JE.
    Am J Hypertens; 2011 Nov 30; 24(11):1164-80. PubMed ID: 21938070
    [Abstract] [Full Text] [Related]

  • 10. Calcium antagonists as a new treatment modality in hypertension.
    Laragh JH.
    Angiology; 1988 Jan 30; 39(1 Pt 2):100-5. PubMed ID: 3277491
    [Abstract] [Full Text] [Related]

  • 11. Volume and vasoconstriction in experimental renovascular hypertension.
    Freeman RH, Davis JO, Seymour AA.
    Fed Proc; 1982 Jun 30; 41(8):2409-14. PubMed ID: 7044827
    [Abstract] [Full Text] [Related]

  • 12. The mechanisms of hypertension and the role of ACE inhibitors.
    Kureya P, Beevers DG.
    J Hum Hypertens; 1991 Dec 30; 5 Suppl 2():3-8. PubMed ID: 1791616
    [Abstract] [Full Text] [Related]

  • 13. The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension.
    Laragh JH, Sealey JE, Niarchos AP, Pickering TG.
    Fed Proc; 1982 Jun 30; 41(8):2415-23. PubMed ID: 7084486
    [Abstract] [Full Text] [Related]

  • 14. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J, Mladenović Lj.
    Srp Arh Celok Lek; 1996 Jun 30; 124(9-10):246-50. PubMed ID: 9102857
    [Abstract] [Full Text] [Related]

  • 15. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J, Karas M, Toal C, Nadeau R, Larochelle P.
    Can J Cardiol; 1999 Mar 30; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [Abstract] [Full Text] [Related]

  • 16. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
    Laragh JH.
    J Hum Hypertens; 1995 Jun 30; 9(6):385-90. PubMed ID: 7473515
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W, Bolli P, Erne P, Hulthén UL, Bühler FR.
    J Cardiovasc Pharmacol; 1987 Jun 30; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [Abstract] [Full Text] [Related]

  • 18. Renovascular hypertension: a paradigm for all hypertension.
    Laragh JH.
    J Hypertens Suppl; 1986 Oct 30; 4(4):S79-88. PubMed ID: 3534186
    [No Abstract] [Full Text] [Related]

  • 19. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS, Gaul SL, Reitz PM, Blaine EH, Ribeiro LT.
    J Hypertens Suppl; 1983 Oct 30; 1(1):53-63. PubMed ID: 6100609
    [Abstract] [Full Text] [Related]

  • 20. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR.
    J Hum Hypertens; 2007 Oct 30; 21(10):770-9. PubMed ID: 17597800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.